Written By: Ashley Simpson, HLG Attorney The Texas Department of State Health Services (“DSHS”) officially adopted rules concerning the manufacture, distribution, and retail sale of consumable hemp products on July 13, which become effective August 2. These rules were drafted to comply with Texas House Bill 1325 (“HB 1325”), which created Texas’ Hemp Program. Pursuant to Texas’ hemp
It seems the latest corruption scandals in the cannabis industry could be just the tip of the iceberg. On December 19, 2019, an undercover FBI agent attended a meeting with two Calexico city officials, Bruno Suarez-Soto and David Romero. He presented himself as a representative of investors seeking to open a cannabis dispensary in Calexico.
Written By: Robert Hoban Hemp legalization has solidified that products containing cannabidiol (CBD) aren’t going away. Last February, Stephen Hahn, Commissioner of the Food and Drug Administration (FDA), acknowledged that it was “a fool's game” to attempt to pull hemp-derived CBD products off the market. This echoes the sentiment of former interim Commissioner, Scott Gottlieb, who’d
The Hoban Minute - 98 | Aurelius Data’s Julie Armstrong | Math is Math/Science is Science Bob and Eric sit down with CEO of Aurelius Data, Julie Armstrong to discuss the spike in Montana COVID cases in the last month, what reputable research indicates about THC consumption and COVID-19, the importance of genetics, industrial hemp’s
The Hoban Minute - 97 | GPIC’s Erick Ponce | The Voice of the Mexican Cannabis Industry Bob and Eric sit down with President of Grupo Promotor de la Industria del Cannabis (GPIC), Erick Ponce to discuss important forthcoming dates for Mexico’s cannabis industry, the valuable work he is going to collate a representative voice
The Hoban Minute – 96 | Cliintel Capital Management Group’s Rick Batenburg III | Where the Puck is Going?
The Hoban Minute - 96 | Cliintel Capital Management Group’s Rick Batenburg III | Where the Puck is Going? Bob and Eric sit down with Founding Partner and Chief Investment Officer of Cliintel Capital Management Group, Rick Batenburg III to discuss the overall condition of the cannabis market, forecasting where the industry is going, and
The Hoban Minute – 95 | FoliuMed’s Oliver Zugel | How European Market Realities Differ from North America and Why it Matters
The Hoban Minute - 95 | FoliuMed’s Oliver Zugel | How European Market Realities Differ from North America and Why it Matters Bob and Eric sit down with the Founder and CEO of FoliuMed Holdings, Oliver Zugel to discuss the recent news that the European Commission is considering labeling CBD as a narcotic rather than
The Hoban Minute – 94 | Wounded Warrior Project’s Sal Gonzalez | A Veteran’s Perspective on Cannabis
The Hoban Minute - 94 | Wounded Warrior Project’s Sal Gonzalez | A Veteran’s Perspective on Cannabis Bob and Eric sit down with Wounded Warrior Project spokesperson and musician, Sal Gonzalez to discuss his advocacy for veteran access to cannabis, his love of playing the guitar and singing, and his experience on America’s Got Talent.
The medical cannabis market in Maryland is flourishing, with sales rapidly moving toward half a billion dollars a year. Experts credit that success, in part, to clear and transparent regulations – and regulators who have balanced compliance with patient access. But a huge lingering issue looms: litigation and investigations into a 2019 licensing round that
Hemp opportunities don’t stop at the U.S. borders, nor are they relegated to North America. Opportunities abound around the globe – with more coming into play all the time. In this webinar, our panelists – Bob Hoban, founder and president of Hoban Law Group, and Sarah Yetman, CEO of Sovereignport, examine: How to identify the